E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Remo H.M. Furtado,Remo H.M. Furtado,Jose C. Nicolau,Giulia Magnani,KyungAh Im,Deepak L. Bhatt,Robert F. Storey,P. Gabriel Steg,Jindrich Spinar,Andrzej Budaj,Frederic Kontny,Ramón Corbalán,Róbert Gábor Kiss,Maria Teresa B. Abola,Per Johanson,Eva C. Jensen,Eugene Braunwald,Marc S. Sabatine,Marc P. Bonaca,Marc P. Bonaca +19 more
TL;DR: Data from PEGASUS-TIMI 54 highlight the benefits of DAPT in prevention of spontaneous atherothrombotic events and indicate that long-term ticagrelor may be considered in high-risk patients with prior MI even if they have not been treated with stenting.
Journal ArticleDOI
Performance of the thrombolysis in myocardial infarction risk index for early acute coronary syndrome in the national registry of myocardial infarction: A simple risk index predicts mortality in both ST and non-ST elevation myocardial infarction
Stephen D. Wiviott,David A. Morrow,Robert P. Giugliano,Paul D. Frederick,Carolyn H. McCabe,Christopher P. Cannon,Elliott M. Antman,Eugene Braunwald +7 more
Journal ArticleDOI
Carotid sinus nerve stimulation for the treatment of intractable angina pectoris: surgical technic.
Journal ArticleDOI
Prospective Validation of a Composite End Point in Thrombolytic Trials of Acute Myocardial Infarction (TIMI 4 and 5)
Christopher P. Cannon,Peter J. Sharis,Marc J. Schweiger,Carolyn H. McCabe,Daniel J. Diver,Prediman K. Shah,Rafael F. Sequeira,Robert M. Greene,Rebecca Perritt,W. Kenneth Poole,Eugene Braunwald +10 more
TL;DR: It is shown that these nonfatal in-hospital end points and the composite end point are associated with an increased risk of 1-year mortality and as such are valid predictive survival markers for use in clinical trials.
Journal ArticleDOI
The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: A multicenter, randomized, double-blind, placebo-controlled clinical trial
Peter Stone,James H. Ware,Marcus A. DeWood,Joel M. Gore,Robert H Eich,Daniel A. Pietro,Alfred F. Parisi,Richard W. Nesto,William E. Boden,Satish C. Sharma,Stephen C Vlay,Len E Ennis,Ralph E Gianelly,Zoltan G. Turi,Nancy Taplin McCall,Dorothy G Curtis,Sergio Chierchia,Attilio Maseri,Eugene Braunwald +18 more
TL;DR: It is concluded that patients with mixed angina are more likely to benefit symptomatically from the addition of nifedipine therapy than patients with classic exertional angina, and episodic coronary vasoconstriction may not be the only mechanism responsible for ischemia in these patients.